Phase 3 Pulmonary Disease, Chronic Obstructive trials recruiting now

All Pulmonary Disease, Chronic Obstructive trials, every phase

Phase 3 Pulmonary Disease, Chronic Obstructive trials

• A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
  NCT07780669 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA -1)
  NCT06959095 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 15 locations
• Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
  NCT06961214 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 159 locations
• Trial to Determine Effective Aspirin Dose in COPD
  NCT05265299 · Phase: Phase 3 · Ages: 40 Years to 80 Years · Sex: All (male and female) · 1 location
• eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
  NCT07177339 · Phase: Phase 3 · Ages: 40 Years to 75 Years · Sex: All (male and female) · 121 locations

Common questions

What does Phase 3 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.